24^th World Hematology Congress

Biomarkers in Hematology.

Biomarkers in hematology were mostly of protein biomarkers which are helpful to detect the tumours early location and mainly to identify bosom growth, these biomarkers simply used to measure and indicate the severity level of disease state. Where as these haematological biomarkers are helpful in identifying the blood disease. Patients who are suspected with pancreatic malignancy will face CT sweep. Recolors neoplastic pancreatic cells will empower the certainty to identify pancreatic tumour by pathologist and hence suitable for treating disease condition. For pancreatic disease a novel drug discovery in biomarkers like BI-010 and IHC markers are developed.

• Drug Targeting.
• Prognosis and treatment production.
• Pharmacodynamics and Pharmacokinetics.
• Monitoring treatment response.